News about Ark Invest

Ark Invest's Q3 report shows 10x Genomics (TXG) was the standout winner, adding 9.03 points to ARKG's 28.92% gain, driven by interest in single-cell sequencing for AI drug-discovery data. Twist Bioscience (TWST, up 87.83%) and Tempus AI (TEM, up 41.38%) also contributed strongly, while Palantir (PLTR) boosted several ETFs. Tesla (TSLA) was the most consistent drag, subtracting 1.72 points from ARKQ and 1.75 points from ARKK after weak second-quarter profitability, although the stock recovered as it launched Cybercab and passed 1 million unsupervised robotaxi miles. Rocket Lab (RKLB) also weighed on space-focused funds, subtracting 2.04 points from ARKX. ARKK fell nearly 5% in Friday's regular session.